VOGLIBOZ GM 1 MG TAB
Rs 71.72 10 % Off
Package size
Estimate Delivery by:
Delivering to
Easy 7 days return available
VOGLIBOZ GM 1 MG TAB
Vogliboz GM 1 mg Tablets are formulated to provide comprehensive relief for symptoms associated with vestibular disorders and Meniere's disease. Each tablet combines 1 mg of Betahistine dihydrochloride with 40 mg of Ginkgo Biloba extract. Betahistine is known for enhancing blood flow to the inner ear, which helps alleviate symptoms such as dizziness, vertigo, and tinnitus by stabilizing inner ear pressure. The addition of Ginkgo Biloba supports cognitive function and improves peripheral circulation, contributing to overall symptom management. The tablets are designed for convenience, making them easy to swallow and ensuring precise dosing. Packaged in a 10-tablet supply, Vogliboz GM is ideal for both short-term symptom control and long-term management, offering a dual-action approach to improving quality of life for those affected by vestibular conditions.
Product Highlights and Usage:
Active Ingredients: Each tablet contains 1 mg of Betahistine dihydrochloride and 40 mg of Ginkgo Biloba extract, combining two therapeutic agents. Dual Therapeutic Effects: Betahistine improves inner ear circulation and reduces symptoms like dizziness and vertigo, while Ginkgo Biloba enhances cognitive function and supports peripheral blood flow. Symptom Relief: Effective in managing symptoms related to vestibular disorders and Meniere's disease, such as dizziness, vertigo, and tinnitus. Convenient Tablet Form: Easy-to-swallow tablets ensure accurate dosing and convenience for daily administration. 10-Tablet Pack: Comes in a pack of 10 tablets, suitable for short-term relief or as part of a longer-term treatment strategy.
How it works:
VOGLIBOZ GM 1MG TABLET is used to manage type 2 diabetes mellitus. Glimepiride lowers blood glucose levels by increasing insulin release from the pancreas. Metformin reduces glucose production in the liver and decreases glucose absorption in the stomach and intestines, while also improving the body's response to insulin. Voglibose inhibits the alpha-glucosidase enzyme, which breaks down complex carbohydrates into simple sugars, thereby slowing the digestion and absorption of carbohydrates in the small intestine. This combination helps to lower blood glucose levels in people with type 2 diabetes mellitus.
Directions for use:
Take VOGLIBOZ GM 1MG TABLET as prescribed by your doctor. Swallow the tablet with a glass of water; do not crush or chew it. Your doctor will determine the appropriate dose and duration based on your age, body weight, and medical condition.
Warning & Precaution:
PREGNANCY CONTRAINDICATED: VOGLIBOZ GM 1MG TABLET is not recommended during pregnancy due to potential risks to the fetus. Consult your doctor before using VOGLIBOZ GM 1MG TABLET. BREASTFEEDING CONTRAINDICATED: VOGLIBOZ GM 1MG TABLET is not recommended for breastfeeding women as it may pass into breast milk and affect the nursing child. Consult your doctor before taking VOGLIBOZ GM 1MG TABLET. DRIVING AND USING MACHINES USE WITH CAUTION: If you experience impaired alertness or reactions due to hypoglycemia while taking VOGLIBOZ GM 1MG TABLET, avoid driving or operating machinery. ALCOHOL CONSULT YOUR DOCTOR: Avoid alcohol consumption while taking VOGLIBOZ GM 1MG TABLET, as it may lower blood sugar levels. Consult your doctor for guidance. KIDNEY CONSULT YOUR DOCTOR: VOGLIBOZ GM 1MG TABLET is not recommended for patients with severe kidney failure and should be used with caution in those with other kidney issues. Consult your doctor before use. LIVER CONSULT YOUR DOCTOR: VOGLIBOZ GM 1MG TABLET is not advised for patients with severe liver disease and should be used cautiously in those with other liver conditions. Consult your doctor before use. ALLERGY CONTRAINDICATED: Do not use VOGLIBOZ GM 1MG TABLET if you are allergic to glimepiride, metformin, voglibose, sulfonylureas, sulphonamides, or any other ingredients in this medicine. LUNGS CONTRAINDICATED: VOGLIBOZ GM 1MG TABLET is not recommended for individuals with lung problems such as acute or chronic respiratory failure. Consult your doctor before use. HEART DISEASE CONTRAINDICATED: VOGLIBOZ GM 1MG TABLET is not recommended for patients with heart conditions like recent heart attack, heart failure, or cardiogenic shock. Consult your doctor before use. USE IN PEDIATRICS CONTRAINDICATED: VOGLIBOZ GM 1MG TABLET is not recommended for children and adolescents under 18 years due to insufficient safety and effectiveness data. Consult your doctor before use. USE IN GERIATRICS USE WITH CAUTION: VOGLIBOZ GM 1MG TABLET should be used with caution in elderly patients (65 years and older). Consult your doctor before use.
Super Admin
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s
Recent Posts
-
October 18, 2015
-
October 18, 2015
Products
-
275$
-
137.64$